Amedica Corporation  

(Public, NASDAQ:AMDA)   Watch this stock  
Find more results for AMDA
3.74
+0.28 (8.09%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.35 - 3.92
52 week 2.95 - 13.08
Open 3.57
Vol / Avg. 75,317.00/150,261.00
Mkt cap 11.30M
P/E     -
Div/yield     -
EPS -4.08
Shares 3.02M
Beta -1.99
Inst. own 11%
Nov 21, 2017
Q3 2017 Amedica Corp Earnings Call - 11:00AM EST - Add to calendar
Nov 21, 2017
Q3 2017 Amedica Corp Earnings Release Add to calendar
Sep 22, 2017
Q1 2017 Amedica Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -95.23% -109.01%
Operating margin -86.47% -80.10%
EBITD margin - -63.04%
Return on average assets -52.21% -53.44%
Return on average equity -91.10% -162.11%
Employees 35 -
CDP Score - -

Address

1885 West 2100 Street
SALT LAKE CITY, UT 84119
United States - Map
+1-801-8393516 (Phone)
+1-801-8393605 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

Officers and directors

B. Sonny Bal M.D. Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Bryan J. McEntire Chief Technology Officer
Age: 63
Bio & Compensation  - Reuters
Dana Lyons Vice President - Sales and Marketing
Bio & Compensation  - Reuters
Eric A. Stookey Independent Director
Age: 44
Bio & Compensation  - Reuters
David W. Truetzel CPA Independent Director
Age: 58
Bio & Compensation  - Reuters
Jeffrey S. White Independent Director
Age: 61
Bio & Compensation  - Reuters